168 related articles for article (PubMed ID: 11811789)
41. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
Vernallis AB; Hudson KR; Heath JK
J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.
Gu ZJ; Costes V; Lu ZY; Zhang XG; Pitard V; Moreau JF; Bataille R; Wijdenes J; Rossi JF; Klein B
Blood; 1996 Nov; 88(10):3972-86. PubMed ID: 8916964
[TBL] [Abstract][Full Text] [Related]
43. Oncostatin M is produced during pregnancy by decidual cells and stimulates the release of HCG.
Ogata I; Shimoya K; Moriyama A; Shiki Y; Matsumura Y; Yamanaka K; Nobunaga T; Tokugawa Y; Kimura T; Koyama M; Azuma C; Murata Y
Mol Hum Reprod; 2000 Aug; 6(8):750-7. PubMed ID: 10908286
[TBL] [Abstract][Full Text] [Related]
44. Are LIF and related cytokines functionally equivalent?
Piquet-Pellorce C; Grey L; Mereau A; Heath JK
Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
[TBL] [Abstract][Full Text] [Related]
45. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
46. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
47. Gp130 in human myeloma/plasmacytoma.
Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
[No Abstract] [Full Text] [Related]
48. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
Liu H; Dan J; Tang S; Wu S
Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
[TBL] [Abstract][Full Text] [Related]
49. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
50. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction.
Starr R; Novak U; Willson TA; Inglese M; Murphy V; Alexander WS; Metcalf D; Nicola NA; Hilton DJ; Ernst M
J Biol Chem; 1997 Aug; 272(32):19982-6. PubMed ID: 9242667
[TBL] [Abstract][Full Text] [Related]
51. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma.
Zhang JG; Zhang Y; Owczarek CM; Ward LD; Moritz RL; Simpson RJ; Yasukawa K; Nicola NA
J Biol Chem; 1998 Apr; 273(17):10798-805. PubMed ID: 9553147
[TBL] [Abstract][Full Text] [Related]
53. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.
Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ
J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900
[TBL] [Abstract][Full Text] [Related]
54. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
55. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
Rose TM; Weiford DM; Gunderson NL; Bruce AG
Cytokine; 1994 Jan; 6(1):48-54. PubMed ID: 8003633
[TBL] [Abstract][Full Text] [Related]
56. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
[TBL] [Abstract][Full Text] [Related]
57. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines.
Li QL; Jansen E; Friedman TC
Mol Cell Endocrinol; 1999 Dec; 158(1-2):143-52. PubMed ID: 10630414
[TBL] [Abstract][Full Text] [Related]
58. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
[TBL] [Abstract][Full Text] [Related]
59. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.
Hurst SM; McLoughlin RM; Monslow J; Owens S; Morgan L; Fuller GM; Topley N; Jones SA
J Immunol; 2002 Nov; 169(9):5244-51. PubMed ID: 12391243
[TBL] [Abstract][Full Text] [Related]
60. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
